Attention: This is an archive version of the HELP CDSS for documentation purposes. It is neither updated nor actively maintained!
Note: Use of ideal body weight
GFR >50 1 x 10 mg/kg distributed over 1-2 doses
GFR 30-50
GFR <30
CHD
CVVH

CAVE:
Interaction check with co-medication!
Regular control of ASAT, ALAT and bilirubin
Explanatory Notes:
Advantages: Good bioavailability, therefore also usable as a combination partner in the context of oral sequence therapy
Disadvantages: High interaction potential
Abbreviations:
CHD Chronic hemodialysis
CVVH Continuous venovenous hemofiltration
GFR Glomerular filtration rate